PubMed

BRCA1/2 genetic background-based therapeutic tailoring of human ovarian cancer: hope or reality?

Tagliaferri P, Ventura M, Baudi F, Cucinotto I, Arbitrio M, Di Martino MT, Tassone P.

J Ovarian Res. 2009 Oct 13;2:14.PMID: 19825178 [PubMed - in process]Related articlesFree article

"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.

Tan DS, Rothermundt C, Thomas K, Bancroft E, Eeles R, Shanley S, Ardern-Jones A, Norman A, Kaye SB, Gore ME.

J Clin Oncol. 2008 Dec 1;26(34):5530-6. Epub 2008 Oct 27.PMID: 18955455 [PubMed - indexed for MEDLINE]Related articles

BRCA1 and implications for response to chemotherapy in ovarian cancer.

Quinn JE, Carser JE, James CR, Kennedy RD, Harkin DP.

Gynecol Oncol. 2009 Apr;113(1):134-42. Epub 2009 Jan 24. Review.PMID: 19168207 [PubMed - indexed for MEDLINE]Related articles

BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation.

Vaidyanathan K, Lakhotia S, Ravishankar HM, Tabassum U, Mukherjee G, Somasundaram K.

J Biosci. 2009 Sep;34(3):415-22.PMID: 19805903 [PubMed - indexed for MEDLINE]Related articlesFree article

Molecular profiles of hereditary epithelial ovarian cancers and their implications for the biology of this disease.

Jazaeri AA.

Mol Oncol. 2009 Apr;3(2):151-6. Epub 2009 Feb 7. Review.PMID: 19383376 [PubMed - indexed for MEDLINE]Related articles

The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian Cancer.

Gien LT, Mackay HJ.

J Oncol. 2010;2010:151750. Epub 2009 Dec 16.PMID: 20049345 [PubMed - in process]Related articlesFree article

Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas.

Walsh CS, Ogawa S, Scoles DR, Miller CW, Kawamata N, Narod SA, Koeffler HP, Karlan BY.

Clin Cancer Res. 2008 Dec 1;14(23):7645-51.PMID: 19047089 [PubMed - indexed for MEDLINE]Related articlesFree article

Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway.

Weberpals JI, Clark-Knowles KV, Vanderhyden BC.

J Clin Oncol. 2008 Jul 1;26(19):3259-67. Review.PMID: 18591560 [PubMed - indexed for MEDLINE]Related articles

The contribution of BRCA1 and BRCA2 to ovarian cancer.

Ramus SJ, Gayther SA.

Mol Oncol. 2009 Apr;3(2):138-50. Epub 2009 Feb 10. Review.PMID: 19383375 [PubMed - indexed for MEDLINE]Related articles

Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer.

Dombernowsky SL, Weischer M, Freiberg JJ, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2339-42.PMID: 19661094 [PubMed - indexed for MEDLINE]Related articles

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas.

Swisher EM, Gonzalez RM, Taniguchi T, Garcia RL, Walsh T, Goff BA, Welcsh P.

Mol Cancer. 2009 Jul 14;8:48.PMID: 19602291 [PubMed - indexed for MEDLINE]Related articlesFree article

Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.

Armaou S, Pertesi M, Fostira F, Thodi G, Athanasopoulos PS, Kamakari S, Athanasiou A, Gogas H, Yannoukakos D, Fountzilas G, Konstantopoulou I.

Br J Cancer. 2009 Jul 7;101(1):32-7. Epub 2009 Jun 2.PMID: 19491894 [PubMed - indexed for MEDLINE]Related articles

BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer.

Clark-Knowles KV, O'Brien AM, Weberpals JI.

J Oncol. 2010;2010:891059. Epub 2010 Feb 22.PMID: 20182637 [PubMed - in process]Related articlesFree article

Clinical and pathologic differences between BRCA1-, BRCA2-, and non-BRCA-associated breast cancers in a multiracial developing country.

Yip CH, Taib NA, Choo WY, Rampal S, Thong MK, Teo SH.

World J Surg. 2009 Oct;33(10):2077-81.PMID: 19649760 [PubMed - indexed for MEDLINE]Related articles

BRCA in breast cancer: From risk assessment to therapeutic prediction.

Diamond JR, Borges VF, Eckhardt SG, Jimeno A.

Drug News Perspect. 2009 Dec;22(10):603-8.PMID: 20140280 [PubMed - in process]Related articles

BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.

Lim MC, Kang S, Seo SS, Kong SY, Lee BY, Lee SK, Park SY.

J Cancer Res Clin Oncol. 2009 Nov;135(11):1593-9. Epub 2009 Jun 5.PMID: 19499246 [PubMed - indexed for MEDLINE]Related articles

A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population.

Palomba G, Loi A, Uras A, Fancello P, Piras G, Gabbas A, Cossu A, Budroni M, Contu A, Tanda F, Farris A, Orrù S, Floris C, Pisano M, Lovicu M, Santona MC, Landriscina G, Crisponi L, Palmieri G, Monne M.

BMC Cancer. 2009 Jul 20;9:245.PMID: 19619314 [PubMed - indexed for MEDLINE]Related articlesFree article

MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary.

Lee CH, Subramanian S, Beck AH, Espinosa I, Senz J, Zhu SX, Huntsman D, van de Rijn M, Gilks CB.

PLoS One. 2009 Oct 2;4(10):e7314.PMID: 19798417 [PubMed - in process]Related articlesFree article

Mutational analysis of BRCA1 and BRCA2 genes in Mexican breast cancer patients.

Vidal-Millán S, Taja-Chayeb L, Gutiérrez-Hernández O, Ramírez Ugalde MT, Robles-Vidal C, Bargallo-Rocha E, Mohar-Betancourt A, Dueñas-González A.

Eur J Gynaecol Oncol. 2009;30(5):527-30.PMID: 19899408 [PubMed - indexed for MEDLINE]Related articles

The preclinical natural history of serous ovarian cancer: defining the target for early detection.

Brown PO, Palmer C.

PLoS Med. 2009 Jul;6(7):e1000114. Epub 2009 Jul 28.PMID: 19636370 [PubMed - indexed for MEDLINE]Related articlesFree article